Lista de obras -

4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study.

artículo científico publicado en 2014

A microarray-based gene expression analysis to identify diagnostic biomarkers for unknown primary cancer

artículo científico publicado en 2013

A randomized phase II trial of trastuzumab plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with trastuzumab and taxanes: WJOG6110B/ELTOP

artículo científico publicado en 2018

Analysis of the clinicopathological prognosis of stage IVb cervical carcinoma

scientific article published on 01 February 2008

Ancient Evolutionary History of Human Papillomavirus Type 16, 18 and 58 Variants Prevalent Exclusively in Japan

artículo científico publicado en 2022

Association between carotenoids and outcome of cervical intraepithelial neoplasia: a prospective cohort study

artículo científico publicado en 2012

Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer

artículo científico publicado en 2009

Clinicopathologic implications of DNA mismatch repair status in endometrial carcinomas.

artículo científico publicado en 2015

Comparison of tumor regression rate of uterine cervical squamous cell carcinoma during external beam and intracavitary radiotherapy

artículo científico publicado en 2008

Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast

artículo científico publicado en 2006

Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis

artículo científico publicado en 2016

Distinct lymphatic spread of endometrial carcinoma in comparison with cervical and ovarian carcinomas

artículo científico publicado en 2002

Diversity in size and signal intensity in multilocular cystic ovarian masses: new parameters for distinguishing metastatic from primary mucinous ovarian neoplasms.

artículo científico publicado en 2013

Do neutralizing antibody responses generated by human papillomavirus infections favor a better outcome of low-grade cervical lesions?

artículo científico publicado en 2012

Do we need a different strategy for HPV screening and vaccination in East Asia?

scientific article published on 01 December 2006

Early impact of the Japanese immunization program implemented before the HPV vaccination crisis

artículo científico publicado en 2017

Efficacy and safety of nivolumab in Japanese patients with uterine cervical cancer, uterine corpus cancer, or soft tissue sarcoma: Multicenter, open-label phase 2 trial

scientific article published on 03 September 2019

Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer

artículo científico publicado en 2005

Evidence for the presence of neutralizing antibodies against human papillomavirus type 6 in infants born to mothers with condyloma acuminata.

artículo científico publicado en 2003

Expression of Tissue Factor in Epithelial Ovarian Carcinoma Is Involved in the Development of Venous Thromboembolism

artículo científico publicado en 2016

Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients

scientific article published on 19 November 2019

Guideline for Gynecological Practice in Japan: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists 2020 edition

artículo científico publicado en 2020

Guidelines for office gynecology in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2017 edition

scientific article published on 24 January 2019

Guidelines for office gynecology in Japan: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists 2011 edition

artículo científico publicado en 2012

HLA class II DRB1*1302 allele protects against progression to cervical intraepithelial neoplasia grade 3: a multicenter prospective cohort study

artículo científico publicado en 2012

HPV genotype contribution to cervical cancer and precancer: implication for screening and vaccination in Japan

scientific article published on 06 May 2020

HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study

artículo científico publicado en 2015

High Levels of Within-Host Variations of Human Papillomavirus 16 <i>E1/E2</i> Genes in Invasive Cervical Cancer

scientific article published on 24 November 2020

High Pretreatment Plasma D-dimer Levels Are Associated With Poor Prognosis in Patients With Ovarian Cancer Independently of Venous Thromboembolism and Tumor Extension

artículo científico publicado en 2015

Human Papillomavirus (HPV) Genotyping Assay Suitable for Monitoring the Impact of the 9-Valent HPV Vaccine

artículo científico publicado en 2020

Human leukocyte antigen class II DRB1*1302 allele protects against cervical cancer: At which step of multistage carcinogenesis?

artículo científico publicado en 2015

Human papillomavirus genotype and prognosis of cervical cancer: favorable survival of patients with HPV16-positive tumors

Human papillomavirus infection and the risk of cervical cancer in Japan

artículo científico

Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer

artículo científico publicado en 2009

Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer

scientific article published on 01 October 2003

IgG antibodies to HPV16, 52, 58 and 6 L1-capsids and spontaneous regression of cervical intraepithelial neoplasia

scientific article published on 01 January 2006

IgG antibodies to human papillomavirus 16, 52, 58, and 6 L1 capsids: case-control study of cervical intraepithelial neoplasia in Japan

artículo científico publicado en 2003

Incidence of venous thromboembolism before treatment in cervical cancer and the impact of management on venous thromboembolism after commencement of treatment.

artículo científico publicado en 2013

Interleukin-10 -1082 gene polymorphism and susceptibility to cervical cancer among Japanese women

artículo científico publicado en 2010

Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.

artículo científico publicado en 2006

Molecular epidemiology of human papillomavirus 18 infections in Japanese Women

artículo científico publicado en 2020

Monitoring the impact of a national HPV vaccination program in Japan (MINT Study): rationale, design and methods

artículo científico publicado en 2014

Monoclonal antibodies recognizing cross-neutralization epitopes in human papillomavirus 16 minor capsid protein L2.

artículo científico publicado en 2012

Neutralizing antibodies against human papillomavirus types 16, 18, 31, 52, and 58 in serum samples from women in Japan with low-grade cervical intraepithelial neoplasia

artículo científico publicado en 2008

Optimizing biopsy procedures during colposcopy for women with abnormal cervical cancer screening results: a multicenter prospective study

artículo científico publicado en 2014

Ovarian serous surface papillary borderline tumors form sea anemone‐like masses ⬇️

artículo científico publicado el 1 de febrero de 2011

PARP inhibitors for BRCA wild type ovarian cancer; gene alterations, homologous recombination deficiency and combination therapy

artículo científico publicado en 2019

PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma

artículo científico publicado en 2012

Pembrolizumab monotherapy in Japanese patients with advanced ovarian cancer: Subgroup analysis from the KEYNOTE-100

artículo científico publicado en 2020

Pharmacotherapy for recurrent ovarian cancer: current status and future perspectives

artículo científico publicado en 2015

Phase 1 dose-escalation study of single-agent veliparib in Japanese patients with advanced solid tumors

artículo científico publicado en 2017

Phase II study of oral etoposide and intravenous irinotecan for patients with platinum-resistant and taxane-pretreated ovarian cancer: Japan Clinical Oncology Group Study 0503

artículo científico publicado en 2012

Phase II trial of oral etoposide plus intravenous irinotecan in patients with platinum-resistant and taxane-pretreated ovarian cancer (JCOG0503).

artículo científico publicado en 2014

Phase III trial of upfront debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0602

artículo científico publicado en 2008

Posttreatment human papillomavirus testing for residual or recurrent high-grade cervical intraepithelial neoplasia: a pooled analysis.

artículo científico publicado en 2015

Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: A prospective cohort study ⬇️

artículo científico publicado el 13 de octubre de 2010

Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy

artículo científico publicado en 2006

Pretreatment thrombocytosis as an independent predictive factor for chemoresistance and poor survival in epithelial ovarian cancer

scientific article published on 06 May 2020

Proposal for selection criteria of secondary cytoreductive surgery in recurrent epithelial ovarian, tubal, and peritoneal cancers

artículo científico publicado en 2015

Questionnaire survey of treatment choice for breast cancer patients with brain metastasis in Japan: results of a nationwide survey by the task force of the Japanese Breast Cancer Society

artículo científico publicado en 2008

Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site

scientific article published on 17 January 2019

Rapid genotyping of carcinogenic human papillomavirus by loop-mediated isothermal amplification using a new automated DNA test (Clinichip HPV™).

artículo científico publicado en 2012

Reduction in HPV16/18 prevalence among young women with high-grade cervical lesions following the Japanese HPV vaccination program

scientific article published on 04 November 2019

Revised FIGO staging system for cancer of the ovary, fallopian tube, and peritoneum: important implications for radiologists

artículo científico

Safety and Relative Dose Intensity of Dose-dense Doxorubicin and Cyclophosphamide Followed by Dose-dense Paclitaxel

artículo científico publicado en 2019

Safety and efficacy of substituting nedaplatin after carboplatin hypersensitivity reactions in gynecologic malignancies

scientific article published on 28 May 2012

Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression.

artículo científico publicado en 2018

Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site: A Nonrandomized Phase 2 Clinical Trial

scientific article published on 15 October 2020

Solid non-invasive ovarian masses on MR: histopathology and a diagnostic approach

artículo científico publicado en 2010

Spontaneous regression of quiescent gestational trophoblastic disease after pregnancy: a case report

artículo científico publicado en 2019

Subsequent risks for cervical precancer and cancer in women with low-grade squamous intraepithelial lesions unconfirmed by colposcopy-directed biopsy: results from a multicenter, prospective, cohort study ⬇️

artículo científico publicado el 13 de julio de 2011

The optimal debulking after neoadjuvant chemotherapy in ovarian cancer: proposal based on interval look during upfront surgery setting treatment

artículo científico publicado en 2009

The safety and efficacy of the weekly dosing of irinotecan for platinum- and taxanes-resistant epithelial ovarian cancer

artículo científico publicado en 2005

Therapeutic effect of dienogest on adenosarcoma arising from endometriosis: a case report

artículo científico publicado en 2013

Three-Dimensional Peripheral Bloodstream Model of the Uterus for Laparoscopic Radical Hysterectomy

artículo científico publicado en 2019

Tobacco smoking and regression of low-grade cervical abnormalities

artículo científico publicado en 2010

Tumor-marker analysis and verification of prognostic models in patients with cancer of unknown primary, receiving platinum-based combination chemotherapy

scientific article published on 22 June 2006

Ultrasound-based logistic regression model LR2 versus magnetic resonance imaging for discriminating between benign and malignant adnexal masses: a prospective study.

artículo científico publicado en 2017

Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy

artículo científico publicado en 2008

Uterine cervical cancer volumetry using T2- and diffusion-weighted MR images in patients treated by primary surgery and neoadjuvant chemotherapy.

artículo científico publicado en 2015

Villin1, a diagnostic marker for endometrial adenocarcinoma with high grade nuclear atypia ⬇️

artículo científico publicado el 1 de agosto de 2011

Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen.

artículo científico publicado en 2007

Whole-Genome Analysis of Human Papillomavirus Type 16 Prevalent in Japanese Women with or without Cervical Lesions.

artículo científico publicado en 2019

Whole-genome analysis of human papillomavirus genotypes 52 and 58 isolated from Japanese women with cervical intraepithelial neoplasia and invasive cervical cancer.

artículo científico publicado en 2017

Within-Host Variations of Human Papillomavirus Reveal APOBEC-Signature Mutagenesis in the Viral Genome

artículo científico publicado en 2018

[A feasibility study of doxorubicin/cisplatin (AP) for postoperative chemotherapy in patients with advanced endometrial cancer]

artículo científico publicado en 2006

[Attention-getting sexually transmitted diseases: Human papillomavirus infections]

scientific article published on 01 November 2007

[Treatment of recurrent ovarian cancer]

artículo científico publicado en 2012

Lista de obras de

4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study.

A microarray-based gene expression analysis to identify diagnostic biomarkers for unknown primary cancer

A randomized phase II trial of trastuzumab plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with trastuzumab and taxanes: WJOG6110B/ELTOP

Analysis of the clinicopathological prognosis of stage IVb cervical carcinoma

Ancient Evolutionary History of Human Papillomavirus Type 16, 18 and 58 Variants Prevalent Exclusively in Japan

Association between carotenoids and outcome of cervical intraepithelial neoplasia: a prospective cohort study

Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer

Clinicopathologic implications of DNA mismatch repair status in endometrial carcinomas.

Comparison of tumor regression rate of uterine cervical squamous cell carcinoma during external beam and intracavitary radiotherapy

Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast

Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis

Distinct lymphatic spread of endometrial carcinoma in comparison with cervical and ovarian carcinomas

Diversity in size and signal intensity in multilocular cystic ovarian masses: new parameters for distinguishing metastatic from primary mucinous ovarian neoplasms.

Do neutralizing antibody responses generated by human papillomavirus infections favor a better outcome of low-grade cervical lesions?

Do we need a different strategy for HPV screening and vaccination in East Asia?

Early impact of the Japanese immunization program implemented before the HPV vaccination crisis

Efficacy and safety of nivolumab in Japanese patients with uterine cervical cancer, uterine corpus cancer, or soft tissue sarcoma: Multicenter, open-label phase 2 trial

Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer

Evidence for the presence of neutralizing antibodies against human papillomavirus type 6 in infants born to mothers with condyloma acuminata.

Expression of Tissue Factor in Epithelial Ovarian Carcinoma Is Involved in the Development of Venous Thromboembolism

Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients

Guideline for Gynecological Practice in Japan: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists 2020 edition

Guidelines for office gynecology in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2017 edition

Guidelines for office gynecology in Japan: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists 2011 edition

HLA class II DRB1*1302 allele protects against progression to cervical intraepithelial neoplasia grade 3: a multicenter prospective cohort study

HPV genotype contribution to cervical cancer and precancer: implication for screening and vaccination in Japan

HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study

High Levels of Within-Host Variations of Human Papillomavirus 16 <i>E1/E2</i> Genes in Invasive Cervical Cancer

High Pretreatment Plasma D-dimer Levels Are Associated With Poor Prognosis in Patients With Ovarian Cancer Independently of Venous Thromboembolism and Tumor Extension

Human Papillomavirus (HPV) Genotyping Assay Suitable for Monitoring the Impact of the 9-Valent HPV Vaccine

Human leukocyte antigen class II DRB1*1302 allele protects against cervical cancer: At which step of multistage carcinogenesis?

Human papillomavirus genotype and prognosis of cervical cancer: favorable survival of patients with HPV16-positive tumors

Human papillomavirus infection and the risk of cervical cancer in Japan

Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer

Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer

IgG antibodies to HPV16, 52, 58 and 6 L1-capsids and spontaneous regression of cervical intraepithelial neoplasia

IgG antibodies to human papillomavirus 16, 52, 58, and 6 L1 capsids: case-control study of cervical intraepithelial neoplasia in Japan

Incidence of venous thromboembolism before treatment in cervical cancer and the impact of management on venous thromboembolism after commencement of treatment.

Interleukin-10 -1082 gene polymorphism and susceptibility to cervical cancer among Japanese women

Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.

Molecular epidemiology of human papillomavirus 18 infections in Japanese Women

Monitoring the impact of a national HPV vaccination program in Japan (MINT Study): rationale, design and methods

Monoclonal antibodies recognizing cross-neutralization epitopes in human papillomavirus 16 minor capsid protein L2.

Neutralizing antibodies against human papillomavirus types 16, 18, 31, 52, and 58 in serum samples from women in Japan with low-grade cervical intraepithelial neoplasia

Optimizing biopsy procedures during colposcopy for women with abnormal cervical cancer screening results: a multicenter prospective study

Ovarian serous surface papillary borderline tumors form sea anemone‐like masses ⬇️

PARP inhibitors for BRCA wild type ovarian cancer; gene alterations, homologous recombination deficiency and combination therapy

PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma

Pembrolizumab monotherapy in Japanese patients with advanced ovarian cancer: Subgroup analysis from the KEYNOTE-100

Pharmacotherapy for recurrent ovarian cancer: current status and future perspectives

Phase 1 dose-escalation study of single-agent veliparib in Japanese patients with advanced solid tumors

Phase II study of oral etoposide and intravenous irinotecan for patients with platinum-resistant and taxane-pretreated ovarian cancer: Japan Clinical Oncology Group Study 0503

Phase II trial of oral etoposide plus intravenous irinotecan in patients with platinum-resistant and taxane-pretreated ovarian cancer (JCOG0503).

Phase III trial of upfront debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0602

Posttreatment human papillomavirus testing for residual or recurrent high-grade cervical intraepithelial neoplasia: a pooled analysis.

Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: A prospective cohort study ⬇️

Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy

Pretreatment thrombocytosis as an independent predictive factor for chemoresistance and poor survival in epithelial ovarian cancer

Proposal for selection criteria of secondary cytoreductive surgery in recurrent epithelial ovarian, tubal, and peritoneal cancers

Questionnaire survey of treatment choice for breast cancer patients with brain metastasis in Japan: results of a nationwide survey by the task force of the Japanese Breast Cancer Society

Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site

Rapid genotyping of carcinogenic human papillomavirus by loop-mediated isothermal amplification using a new automated DNA test (Clinichip HPV™).

Reduction in HPV16/18 prevalence among young women with high-grade cervical lesions following the Japanese HPV vaccination program

Revised FIGO staging system for cancer of the ovary, fallopian tube, and peritoneum: important implications for radiologists

Safety and Relative Dose Intensity of Dose-dense Doxorubicin and Cyclophosphamide Followed by Dose-dense Paclitaxel

Safety and efficacy of substituting nedaplatin after carboplatin hypersensitivity reactions in gynecologic malignancies

Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression.

Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site: A Nonrandomized Phase 2 Clinical Trial

Solid non-invasive ovarian masses on MR: histopathology and a diagnostic approach

Spontaneous regression of quiescent gestational trophoblastic disease after pregnancy: a case report

Subsequent risks for cervical precancer and cancer in women with low-grade squamous intraepithelial lesions unconfirmed by colposcopy-directed biopsy: results from a multicenter, prospective, cohort study ⬇️

The optimal debulking after neoadjuvant chemotherapy in ovarian cancer: proposal based on interval look during upfront surgery setting treatment

The safety and efficacy of the weekly dosing of irinotecan for platinum- and taxanes-resistant epithelial ovarian cancer

Therapeutic effect of dienogest on adenosarcoma arising from endometriosis: a case report

Three-Dimensional Peripheral Bloodstream Model of the Uterus for Laparoscopic Radical Hysterectomy

Tobacco smoking and regression of low-grade cervical abnormalities

Tumor-marker analysis and verification of prognostic models in patients with cancer of unknown primary, receiving platinum-based combination chemotherapy

Ultrasound-based logistic regression model LR2 versus magnetic resonance imaging for discriminating between benign and malignant adnexal masses: a prospective study.

Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy